Featured Research

from universities, journals, and other organizations

Routine lab test data predicts progression to kidney failure for chronic kidney disease patients

Date:
April 11, 2011
Source:
JAMA and Archives Journals
Summary:
A prediction model that included data on measures of several routinely obtained laboratory tests including blood levels of calcium, phosphate and albumin accurately predicted the short-term risk of kidney failure for patients with moderate to severe chronic kidney disease, according to a new study.

A prediction model that included data on measures of several routinely obtained laboratory tests including blood levels of calcium, phosphate and albumin accurately predicted the short-term risk of kidney failure for patients with moderate to severe chronic kidney disease, according to a study that will appear in the April 20 issue of JAMA.

Related Articles


The study is being published early online to coincide with its presentation at the World Congress of Nephrology.

"An estimated 23 million people in the United States (11.5 percent of the adult population) have chronic kidney disease (CKD) and are at increased risk for cardiovascular events and progression to kidney failure," according to background information in the article. "Accurate prediction of risk could facilitate individualized decision making, enabling early and appropriate patient care. Currently, there are no widely accepted predictive instruments for CKD progression; therefore, physicians must make ad hoc decisions about which patients to treat, risking delays in treatment in those who ultimately progress to kidney failure, or unnecessary treatment in those who do not progress."

Navdeep Tangri, M.D., F.R.C.P.C., of Tufts Medical Center, Boston, and colleagues conducted a study to develop and externally validate an accurate but simple prediction model for progression of CKD, with a goal being to use variables routinely measured in patients with CKD to create a model that could be easily implemented in clinical practice. The researchers used demographic, clinical, and laboratory data from 2 independent Canadian groups of patients with CKD stages 3 to 5 (moderate to severe) who were referred to nephrologists between April 2001 and December 2008. The primary outcome measured was kidney failure, defined as need for dialysis or pre-emptive kidney transplantation.

The development and validation groups included 3,449 patients (386 with kidney failure [11 percent]) and 4,942 patients (1,177 with kidney failure [24 percent]), respectively. The researchers found that the most accurate model included age, sex, estimated glomerular filtration rate (GFR), albuminuria, serum calcium, serum phosphate, serum bicarbonate, and serum albumin. In the validation cohort, this model was more accurate than a simpler model that included age, sex, estimated GFR, and albuminuria.

"Our risk prediction models have important implications for clinical practice, research, and public health policy. For example, in CKD stage 3, the relative contribution of the nephrologist vs. the primary care physician to CKD care is uncertain. Using our models, lower-risk patients could be managed by the primary care physician without additional testing or treatment of CKD complications; whereas, higher-risk patients could receive more intensive testing, intervention, and early nephrology care. Similarly, in CKD stage 4, the timing of appropriate predialysis interventions remains uncertain. Using our models, different risk thresholds could be used to triage patients for decisions regarding dialysis modality education, vascular access creation, and pre-emptive transplantation. Furthermore, our models could be used to select higher-risk patients for enrollment in clinical trials and for evaluation of risk-treatment interactions. In addition, our models may also be useful for identifying high-risk patients with CKD stage 3 for public health interventions, thereby improving the cost-effectiveness of CKD care," the authors write.

"In conclusion, we have developed and validated highly accurate predictive models for progression of CKD to kidney failure. Our best model uses routinely available laboratory data and can predict the short-term risk of kidney failure with accuracy and could be easily implemented in a laboratory information system or an electronic health record. External validation in multiple diverse CKD cohorts and evaluation in clinical trials are needed."

Editorial: Supplementing Creatinine-Based Estimates of Risk in Chronic Kidney Disease -- Is It Time?

In an accompanying editorial, Marcello Tonelli, M.D., S.M., F.R.C.P.C., of the University of Alberta, Edmonton, Canada, and Braden Manns, M.D., M.Sc., F.R.C.P.C., of the University of Calgary, Alberta, Canada, comment on the studies in this week's JAMA on risk predictors for patients with kidney disease.

"Developing optimal risk prediction tools is only part of the challenge ahead. Data are urgently needed to clarify how better prognostic information can be incorporated into routine care to improve patient outcomes rather than simply increasing physician workload, the costs of laboratory testing, and the complexity of risk instruments. This seems particularly important given studies showing that routine estimated GFR reporting increased the likelihood of specialist referrals but did not improve outcomes. Achieving this objective will require studies that use other metrics besides discrimination and calibration -- such as assessing the acceptability of risk stratification schemes to primary care physicians and the feasibility of implementation in diverse clinical settings -- and will require studies that demonstrate that using better risk prediction tools will lead to clinically meaningful benefit for patients."


Story Source:

The above story is based on materials provided by JAMA and Archives Journals. Note: Materials may be edited for content and length.


Journal References:

  1. Navdeep Tangri, Lesley A. Stevens, John Griffith, Hocine Tighiouart, Ognjenka Djurdjev, David Naimark, Adeera Levin, Andrew S. Levey. A Predictive Model for Progression of Chronic Kidney Disease to Kidney Failure. JAMA., 2011; DOI: 10.1001/jama.2011.451
  2. Marcello Tonelli, Braden Manns. Supplementing Creatinine-Based Estimates of Risk in Chronic Kidney Disease: Is It Time? JAMA, 2011 DOI: 10.1001/jama.2011.502

Cite This Page:

JAMA and Archives Journals. "Routine lab test data predicts progression to kidney failure for chronic kidney disease patients." ScienceDaily. ScienceDaily, 11 April 2011. <www.sciencedaily.com/releases/2011/04/110411142306.htm>.
JAMA and Archives Journals. (2011, April 11). Routine lab test data predicts progression to kidney failure for chronic kidney disease patients. ScienceDaily. Retrieved November 28, 2014 from www.sciencedaily.com/releases/2011/04/110411142306.htm
JAMA and Archives Journals. "Routine lab test data predicts progression to kidney failure for chronic kidney disease patients." ScienceDaily. www.sciencedaily.com/releases/2011/04/110411142306.htm (accessed November 28, 2014).

Share This


More From ScienceDaily



More Health & Medicine News

Friday, November 28, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Ebola Leaves Orphans Alone in Sierra Leone

Ebola Leaves Orphans Alone in Sierra Leone

AFP (Nov. 27, 2014) — The Ebola epidemic sweeping Sierra Leone is having a profound effect on the country's children, many of whom have been left without any family members to support them. Duration: 01:02 Video provided by AFP
Powered by NewsLook.com
Experimental Ebola Vaccine Shows Promise In Human Trial

Experimental Ebola Vaccine Shows Promise In Human Trial

Newsy (Nov. 27, 2014) — A recent test of a prototype Ebola vaccine generated an immune response to the disease in subjects. Video provided by Newsy
Powered by NewsLook.com
Pet Dogs to Be Used in Anti-Ageing Trial

Pet Dogs to Be Used in Anti-Ageing Trial

Reuters - Innovations Video Online (Nov. 26, 2014) — Researchers in the United States are preparing to discover whether a drug commonly used in human organ transplants can extend the lifespan and health quality of pet dogs. Video provided by Reuters
Powered by NewsLook.com
Today's Prostheses Are More Capable Than Ever

Today's Prostheses Are More Capable Than Ever

Newsy (Nov. 26, 2014) — Advances in prosthetics are making replacement body parts stronger and more lifelike than they’ve ever been. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins